Reviva to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Reviva Pharmaceuticals Holdings (NASDAQ: RVPH), a late-stage pharmaceutical company focusing on CNS, inflammatory, and cardiometabolic diseases, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The event is scheduled for September 9-11, 2024.
Key details include:
- CEO Dr. Laxminarayan Bhat will deliver a corporate update
- A pre-recorded presentation will be available on-demand from September 9, 7:00 a.m. ET
- Management will participate in virtual one-on-one meetings
Investors can access the presentation via a provided webcast link and arrange meetings with management through H.C. Wainwright sales representatives.
Reviva Pharmaceuticals Holdings (NASDAQ: RVPH), una compagnia farmaceutica in fase avanzata che si concentra su malattie del sistema nervoso centrale, infiammatorie e cardiometaboliche, ha annunciato la sua partecipazione alla 26a Conferenza Annuale di Investimenti Globali H.C. Wainwright. L'evento si svolgerà dal 9 all'11 settembre 2024.
Dettagli principali includono:
- Il CEO Dr. Laxminarayan Bhat fornirà un aggiornamento aziendale
- Una presentazione preregistrata sarà disponibile on-demand a partire dal 9 settembre, ore 7:00 ET
- La direzione parteciperà a incontri virtuali one-on-one
Gli investitori possono accedere alla presentazione tramite un link di webcast fornito e organizzare incontri con la direzione attraverso i rappresentanti di vendita H.C. Wainwright.
Reviva Pharmaceuticals Holdings (NASDAQ: RVPH), una empresa farmacéutica en etapa avanzada que se centra en enfermedades del SNC, inflamatorias y cardiometabólicas, ha anunciado su participación en la 26ª Conferencia Anual de Inversiones Globales H.C. Wainwright. El evento está programado para del 9 al 11 de septiembre de 2024.
Los detalles clave incluyen:
- El CEO Dr. Laxminarayan Bhat ofrecerá una actualización corporativa
- Una presentación pregrabada estará disponible bajo demanda a partir del 9 de septiembre, 7:00 a.m. ET
- La dirección participará en reuniones virtuales uno a uno
Los inversionistas pueden acceder a la presentación a través de un enlace de webcast proporcionado y organizar reuniones con la dirección a través de los representantes de ventas de H.C. Wainwright.
Reviva Pharmaceuticals Holdings (NASDAQ: RVPH)는 CNS, 염증 및 심대사 질환에 중점을 둔 후기 단계 제약 회사로, H.C. Wainwright 26차 연례 글로벌 투자 컨퍼런스에 참여할 예정이라고 발표했습니다. 이 행사는 2024년 9월 9일부터 11일까지 진행됩니다.
주요 세부 사항은 다음과 같습니다:
- CEO Dr. Laxminarayan Bhat가 기업 업데이트를 제공합니다
- 사전 녹화된 발표가 9월 9일, 오전 7시 ET부터 온디멘드로 제공됩니다
- 경영진이 가상 일대일 회의에 참여합니다
투자자는 제공된 웹캐스트 링크를 통해 발표에 액세스할 수 있으며, H.C. Wainwright 판매 대표를 통해 경영진과의 회의를 조정할 수 있습니다.
Reviva Pharmaceuticals Holdings (NASDAQ: RVPH), une entreprise pharmaceutique en phase avancée se concentrant sur les maladies du SNC, inflammatoires et cardiométaboliques, a annoncé sa participation à la 26e Conférence Annuelle d'Investissement Mondial H.C. Wainwright. L'événement est prévu du 9 au 11 septembre 2024.
Les principaux détails incluent :
- Le PDG Dr. Laxminarayan Bhat fera une mise à jour sur l'entreprise
- Une présentation préenregistrée sera disponible à la demande à partir du 9 septembre, 7h00 ET
- La direction participera à des réunions virtuelles en tête-à-tête
Les investisseurs peuvent accéder à la présentation via un lien de webcast fourni et organiser des réunions avec la direction par l'intermédiaire des représentants des ventes de H.C. Wainwright.
Reviva Pharmaceuticals Holdings (NASDAQ: RVPH), ein Unternehmen der späten Phase der Pharmaindustrie, das sich auf CNS-, entzündliche und kardiometabolische Erkrankungen konzentriert, hat seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright angekündigt. Die Veranstaltung findet vom 9. bis 11. September 2024 statt.
Zu den wichtigsten Details gehören:
- CEO Dr. Laxminarayan Bhat wird ein Unternehmens-Update geben
- Eine vorab aufgezeichnete Präsentation wird ab dem 9. September, 7:00 Uhr ET auf Abruf verfügbar sein
- Das Management wird an virtuellen Einzelgesprächen teilnehmen
Investoren können über einen bereitgestellten Webcast-Link auf die Präsentation zugreifen und über die Vertriebsmitarbeiter von H.C. Wainwright Meetings mit dem Management vereinbaren.
- None.
- None.
CUPERTINO, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the H.C. Wainwright 26th Annual Global Investment Conference, taking place September 9-11, 2024.
H.C. Wainwright 26th Annual Global Investment Conference
Format: Corporate update
Date/Time: Pre-recorded presentation available on-demand Monday, September 9, at 7:00 a.m. ET
Webcast Link: Click Here
Management will also be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact your H.C. Wainwright sales representative to register for the conference.
About Reviva
Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva’s current pipeline focuses on the central nervous system (CNS), inflammatory and cardiometabolic diseases. Reviva’s pipeline currently includes two drug candidates, brilaroxazine (RP5063) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both brilaroxazine and RP1208 in the United States, Europe, and several other countries.
Corporate Contact:
Reviva Pharmaceuticals Holdings, Inc.
Laxminarayan Bhat, PhD
www.revivapharma.com
Investor Relations Contact:
LifeSci Advisors, LLC
Bruce Mackle
bmackle@lifesciadvisors.com
Media Contact:
Kristin Politi
kpoliti@lifescicomms.com
(646) 876-4783
FAQ
When is Reviva Pharmaceuticals (RVPH) participating in the H.C. Wainwright Global Investment Conference?
Who will be presenting for Reviva Pharmaceuticals (RVPH) at the conference?
What type of presentation will Reviva Pharmaceuticals (RVPH) give at the H.C. Wainwright conference?
Will Reviva Pharmaceuticals (RVPH) management be available for meetings during the conference?
